Titan Pharmaceuticals, Inc. Stock OTC Bulletin Board
Equities
TTNP
US8883141017
Pharmaceuticals
Sales 2022 | 557K 761K | Sales 2023 | 184K 251K | Capitalization | 6.21M 8.49M |
---|---|---|---|---|---|
Net income 2022 | -10M -13.66M | Net income 2023 | -5M -6.83M | EV / Sales 2022 | 15.6 x |
Net cash position 2022 | 2.75M 3.76M | Net cash position 2023 | 6.2M 8.46M | EV / Sales 2023 | 0.11 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.53% |
Members of the board | Title | Age | Since |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 22-08-14 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 23-10-11 |
Brynner Chiam
BRD | Director/Board Member | - | 23-10-11 |
1st Jan change | Capi. | |
---|---|---|
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |